AkashicTEST001 · 16 November 2026
When a Research Reply Becomes a Vendor Referral
One public reply to AKN24 paired health claims with product and shipping language. We tested how the tools rated the wording, compared responses and identified changes for a future review.
AkashicMESSAGE · Read the Wording
🔴 Red overall. The wording presents consequential health and product assurances without supporting evidence. 🟢 Green for patronising wording. A direct instruction and enthusiastic language give little evidence of condescension. Agency is 🟠 Amber because the referral offers a clear next step with little basis for an informed choice.
We reviewed one reply dated 14 November. The two AKN24 posts establish context. The opening could be an informal recommendation. The product descriptions and shipping line support a promotional reading. Affiliation, intent and any transaction remain unknown. The reply does not answer the research findings, so it falls outside Graham’s hierarchy of disagreement.

Seven Excerpts and Their Ratings
| Excerpt | Reading | Evidence | Care | Agency | Patronising wording |
|---|---|---|---|---|---|
| “Look up” | Directs readers to a named account. It could be a friendly tip in a solicited exchange. The visible parent requested no referrals. | 🟠 Amber | 🟠 Amber | 🟠 Amber | 🟢 Green |
| “best tips” | Superlative with no comparison or criteria. Could be informal enthusiasm. | 🟠 Amber | 🟠 Amber | 🟠 Amber | 🟢 Green |
| “helps with chronic pain” and “anxiety related issues” | Health-benefit implication. Could describe advice or support, but the adjacency to products invites a treatment reading. The reply supplies no outcomes, qualifications or evidence. | 🔴 Red | 🔴 Red | 🟠 Amber | 🟢 Green |
| “premium” | Value judgement attached to psilocybin blends. Could express preference. It gives readers no basis to judge composition or quality. | 🟠 Amber | 🟠 Amber | 🟠 Amber | 🟢 Green |
| “high- purity” | Product assurance about ayahuasca. The wording implies measured quality and gives no batch, method or result. | 🔴 Red | 🔴 Red | 🟠 Amber | 🟢 Green |
| “trusted” | Reputation or reliability claim attached to LSD and DMT. It could reflect personal confidence. The reply gives no grounds for extending that confidence to readers. | 🔴 Red | 🔴 Red | 🟠 Amber | 🟢 Green |
| “Shipped swiftly” | Fulfilment assertion and strong signal of a commercial referral. Shipping origin, times and any completed transaction are unknown. | 🟠 Amber | 🟠 Amber | 🟠 Amber | 🟢 Green |
All 19 Living Spectrum Lenses
| Lens | Rating | Evidence |
|---|---|---|
| Logical | 🔴 Red | Assurances are asserted without a supporting chain of evidence. |
| Mathematical | ⚪ Grey | No measured purity, effect size or delivery interval. |
| Intrapersonal | ⚪ Grey | No first-person reflection or self-report. |
| Metacognitive | ⚪ Grey | No account of how the author evaluated or might revise the claims. |
| Emotional | 🟠 Amber | The reply names anxiety but shows no exchange about what someone is feeling or seeking. |
| Interpersonal | 🟠 Amber | Directs readers elsewhere without responding to the parent’s research discussion. |
| Collective | ⚪ Grey | No shared deliberation or community process is described. |
| Linguistic | 🟠 Amber | Concise, actionable wording. Broad adjectives leave the basis and scope unclear. |
| Spatial | ⚪ Grey | No spatial reasoning. |
| Musical | ⚪ Grey | No musical content. |
| Bodily Awareness | ⚪ Grey | Pain is named as a condition, with no embodied observation. |
| Kinesthetic | ⚪ Grey | No movement or skilled bodily action. |
| Tactile | ⚪ Grey | No tactile observation. |
| Naturalistic | ⚪ Grey | Named substances supply no evidence of ecological or naturalistic reasoning. |
| Existential | ⚪ Grey | No question about meaning, mortality or purpose. |
| Spiritual | ⚪ Grey | Naming ayahuasca supplies no evidence about ritual or spiritual experience. |
| Transpersonal | ⚪ Grey | No report of experience beyond the individual. |
| Creative / Imaginative | ⚪ Grey | No material that supports a reading of this lens. |
| Practical / Adaptive | 🟠 Amber | Gives a concrete next step without evidence of suitability or fulfilment. |
AkashicOMNI · 12 Perspectives
| Perspective | Status | Application |
|---|---|---|
| AWAKEN | Applied | Identify the point where a research thread shifts into a referral. |
| HIERATIC | Insufficient information | No tradition, practitioner role or ritual context is described. |
| HOMESENSE | Insufficient information | No lived outcome or direct account of pain or anxiety. |
| ADAPT | Applied | Choose a response proportionate to a public research thread. |
| REGENERATE | Applied | Restore room for study discussion with a clear boundary or quiet moderation. |
| TRANSCEND | Irrelevant | This reply describes no transformation or experience to interpret. |
| METAD | Applied | Test the assumption that apparent relevance to psychedelics makes the referral an answer to the research post. |
| ACTC | Applied | The referral, catalogue and shipping language cohere as promotion. Their coherence supplies no evidence for the claimed benefits. |
| CUT Past | Insufficient information | Prior contact, invitations and account history are unverified. |
| CUT Present | Applied | Check the reply against its directly visible parent and the evidence it supplies. |
| CUT Future | Applied | Compare quiet moderation, a public boundary and an invitation to discuss a specific study. |
| UMASC | Applied | Trace how proximity to research citations may lend perceived credibility to a commercial message, as a possibility about readers’ interpretation. |
AkashicASSESS · Compare Responses
Pain and anxiety research evaluates defined interventions and populations. The neuropathic pain review found some promise and judged the evidence generally low quality. The anxiety trials studied a defined LSD formulation for generalised anxiety disorder and psilocybin in people with life-threatening cancer. These sources do not substantiate the reply’s claims about a vendor, services, quality or shipping.
- Clarifying question. “Which finding in the AKN24 thread are you responding to?” Useful if a research point may be missing.
- Public boundary. State what belongs in the thread. It helps readers understand the discussion standard and may give the referral more visibility.
- Collaborative next step. Invite a specific paper and a checkable finding if there is a research contribution to recover.
- Quiet moderation. Hide the reply and consider reporting it for X to review under its policy on facilitating drug sales. The platform decides whether the rule applies.
Quiet moderation was the recommended response. The published X quote thread is a separate editorial choice. It documents the case and can also surface the original referral to more readers.
Please keep this AKN24 thread focused on the studies and their findings. If you have relevant research to share, a link to the paper is welcome. Please leave vendor referrals and product offers out of the replies.
AkashicENHANCE × AkashicINQUIRY
This manual application uses AkashicENGINE’s research approach. EXPAND² considers competing readings, PRISM informs traceable claim records and RELATE informs boundaries and reply choice. The review draws on the public source and published references.
- AkashicMESSAGE v0.3.0. The health-benefit wording is a factual assurance with no supporting evidence in the reply. Tone remains a separate judgement from the potential health consequences.
- AkashicASSESS v0.2.0. Compare no reply, quiet moderation and public responses. In this case a public quote or vendor link can spread the referral. A brief boundary can help readers with less repetition.

What the Next Test Should Catch
Give independent reviewers a genuine research critique, a solicited peer suggestion and a commercial referral in both the existing and proposed formats. Compare whether they can match ratings to source excerpts, preserve legitimate discussion, flag unsupported assurances and justify their response choices. Record disagreements and false positives before drawing conclusions about effectiveness. Use the blind-review protocol and rubric.
Sources and Methods
- AKN24 parent post · AkashicTEST001 X thread and quoted reply
- Psilocybin and chronic neuropathic pain review · LSD trial in generalised anxiety disorder · Psilocybin trial in life-threatening cancer
- X policy on illegal or regulated goods and services
- Lifestyle Tools · AkashicOMNI specification · Living Spectrum · Graham’s hierarchy

